Use of homoharringtonine in preparation of betacoronavirus replication inhibitor in human Grant US-11850250-B2 United States of America 26 Dec 2023
Genetically encoded system for constructing and detecting biologically active agents Grant US-11472847-B2 United States of America 18 Oct 2022
USE OF MAIT CELLS AS BIOMARKERS AND BIOTARGETS IN COVID-19 Application WO-2022043496-A2 World Intellectual Property Organisation (WIPO) 03 Mar 2022
USE OF HOMOHARRINGTONINE IN PREPARATION OF BETACORONAVIRUS REPLICATION INHIBITOR IN HUMAN Application US-20220016129-A1 United States of America 20 Jan 2022
ANTIVIRAL COMPOUND Application WO-2021249982-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
OPTIMIZED NUCLEOTIDE SEQUENCES ENCODING SARS-COV-2 ANTIGENS Application WO-2021226436-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A LIPOSOMAL FORMULATION… Application WO-2021204873-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A LIPOSOMAL FORMULATION… Application EP-3892296-A1 European Patent Office 13 Oct 2021
USE OF FAVIPIRAVIR IN THE TREATMENT OF CORONAVIRUS INFECTION Application EP-3854398-A1 European Patent Office 28 Jul 2021